Page last updated: 2024-08-22

1-(4-carboxyphenyl)-3,3-dimethyltriazene and Brain Neoplasms

1-(4-carboxyphenyl)-3,3-dimethyltriazene has been researched along with Brain Neoplasms in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19903 (75.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benvenuto, J; Farquhar, D1
Giraldi, T; Grill, V; Mallardi, F; Perissin, L; Sava, G; Zorzet, S1
Giraldi, T; Lassiani, L; Nisi, C; Sava, G1
Crowther, D; Lee, SM; Margison, GP; Thatcher, N1

Trials

1 trial(s) available for 1-(4-carboxyphenyl)-3,3-dimethyltriazene and Brain Neoplasms

ArticleYear
In vivo depletion of O6-alkylguanine-DNA-alkyltransferase in lymphocytes and melanoma of patients treated with CB 10-277, a new DTIC analogue.
    Cancer chemotherapy and pharmacology, 1992, Volume: 31, Issue:3

    Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Dacarbazine; Female; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Lymphocytes; Male; Melanoma; Methyltransferases; Middle Aged; O(6)-Methylguanine-DNA Methyltransferase; Skin Neoplasms; Triazenes

1992

Other Studies

3 other study(ies) available for 1-(4-carboxyphenyl)-3,3-dimethyltriazene and Brain Neoplasms

ArticleYear
1-Aryl-3,3-dimethyltriazenes: potential central nervous system active analogues of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (DTIC).
    Journal of medicinal chemistry, 1984, Volume: 27, Issue:12

    Topics: Animals; Antineoplastic Agents; Blood-Brain Barrier; Brain Neoplasms; Dacarbazine; Drug Evaluation, Preclinical; Ependymoma; Leukemia L1210; Melanoma; Mice; Mice, Inbred Strains; Structure-Activity Relationship

1984
Infiltration of liver and brain by tumor cells in leukemic mice: prevention by dimethyltriazenes and cyclophosphamide.
    Tumori, 1984, Dec-31, Volume: 70, Issue:6

    Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cyclophosphamide; Dacarbazine; Leukemia, Experimental; Liver Neoplasms; Mice; Triazenes

1984
Metabolism and mechanism of the antileukemic action of isomeric aryldimethyltriazenes.
    Cancer treatment reports, 1982, Volume: 66, Issue:9

    Topics: Animals; Antineoplastic Agents; Biotransformation; Brain Neoplasms; Dose-Response Relationship, Drug; Half-Life; Isomerism; Kinetics; Leukemia, Experimental; Lymphoma; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Structure-Activity Relationship; Triazenes

1982